JOHNSON & JOHNSON - 09 Apr 2024 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
10%+ Owner
Signature
Johnson & Johnson By: /s/ Marc Larkins, Secretary
Issuer symbol
CTNM
Transactions as of
09 Apr 2024
Net transactions value
$0
Form type
3
Filing time
10 Apr 2024, 17:05:42 UTC
Previous filing
06 Mar 2024
Next filing
10 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTNM Class A Common Stock 1,979,173 09 Apr 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported as indirectly beneficially owned by Johnson & Johnson are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of Johnson & Johnson.